C21 Investments Inc. (CXXIF)

↓ Download CSV

CIK 0000831609 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated A1
  • Fiscal year ends Mar 31

In fiscal 2026, C21 Investments Inc. reported revenue of $32.61M, up 8.3% from the prior year. The company ran a net loss, with a net margin of -9.9% and a gross margin of 41.7%. It held $54.42M in total assets against $28.99M in total liabilities.

Key ratios (FY2026)

41.7%
Gross margin
7.0%
Operating margin
-9.9%
Net margin
-12.8%
Return on equity
+8.3%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020
Revenue$32.61M$30.12M$28.29M$28.89M$32.98M$33.47M
Cost of Revenue$19.01M$17.56M$17.14M$15.49M$14.17M$15.42M
Gross Profit$13.61M$12.56M$11.15M$13.40M$18.81M$18.05M
Operating Income$2.28M$1.28M$1.47M$3.96M$9.75M$9.24M
Net Income-$3.24M-$3.97M-$3.31M$293.2K$9.95M-$7.83M
EPS (Diluted)$-0.03$-0.03$-0.03$0.00$0.08$-0.07
Total Assets$54.42M$57.00M$55.23M$58.31M$61.84M$66.82M
Total Liabilities$28.99M$28.32M$24.25M$24.00M$28.12M$43.56M
Shareholders' Equity$25.43M$28.68M$30.97M$34.32M$33.73M$23.26M$13.61M
Operating Cash Flow$1.36M$1.37M$3.26M$5.97M$8.44M$8.48M
Capital Expenditures$244.8K$406.7K$521.6K$442.3K$2.56M$227.8K
Shares Outstanding117.84M118.00M120.05M120.05M120.05M117.06M